The European Federation for Exploratory Medicines Development – EUFEMED – was founded in 2015 as a result of an ongoing, informal collaboration between several European societies active in the area of human pharmacology.
EUFEMED has been recognized as a stakeholder by EMA and is consulted for the revision of important European regulations and guidelines related to clinical drug development.
EUFEMED is a not for profit association established under the Belgian law. In order to strengthen the voice of EUFEMED and in the importance of early medicines development in Europe, other societies and additional countries are invited to become members.
19-Oct-2017: EUFEMED 2017 Delegate Feedback Report ...
Methodology Conference attendees (n=214, excluding exhibitors) were sent a link to a web-based questionnaire by email following the close of the meeting. Feedback was collected anonymously. General Questions (n=55) (n=53)… Read More ...Presentations from the EUFEMED 1st Forum in Leuven are available ...
The EUFEMED First Forum in KU Leuven, Belgium has been a great success and we offer the presentations for download. If you want to know more about the EUFEMED Forum… Read More ...02.04.-05.04.2019: Introductory Course in Exploratory Medicines De ...
This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. Two training parts of several days provide a concise overview on Human Pharmacology / Translational… Read More ...19.02.–20.02.2019: EFGCP Annual Conference ...
Making Clinical Research an Element of Better Healthcare EFGCP Annual Conference 2019 focuses on achieving better integration of clinical research in healthcare. Many scientific, methodological and regulatory challenges in research… Read More ...13.02.–15.02.2019: Introductory Course in Exploratory Medicines ...
This course addresses postgraduates in life sciences interested in early clinical development of medicinal products. Two training parts of several days provide a concise overview on Human Pharmacology / Translational… Read More ...24.01.–25.01.2019 AGAH-Workshop on the implementation of TRANSLA ...
Very few tasks in early drug development are as challenging as selecting the adequate starting dose and defining appropriate dose escalation schemes in early clinical trials. About this Workshop… Read More ...24-Apr-2018 – The New First-in-Human EMA Guideline: Disrupti ...
Read the paper. Read the presentations from the meeting. See the programme of the meeting. ...15-17 May 2019 – Lyon Conference, France ...
EUFEMED Conference 2019 – Lyon The Changing Landscape of Early Medicines Development: Be Prepared! EUFEMED will be hosting its next meeting in Lyon, France on 15-17 May 2019. The venue… Read More ...
Upcoming events
About us
EUFEMED represents national and European federations, organisations or associations active in early clinical medicines development.
Based on the successful collaborations since 2007 between our members, their comparable objectives and the growing importance of early clinical drug development EUFEMED strives to be a “voice” in the interest of exploratory medicines development in Europe.
EUFEMED promotes the interest of early clinical medicines development in professional organisations, international organisations and public authorities.
Our aims are to help the members in all professional fields, organise meetings and conferences, courses and specialist training, and much more… We develop standards and promote guidance documents in early medicines development in order to improve European competitiveness.
Join us!
Become a full member or an associate member of EUFEMED and profit from the advantages!
Get in touch
If you are interested in working together, send us an inquiry and we will get back to you as soon as we can!
Contact us